Canada markets closed

Syros Pharmaceuticals, Inc. (SYRS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.04-0.06 (-1.18%)
At close: 04:00PM EDT
4.97 -0.07 (-1.39%)
After hours: 05:30PM EDT
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Cash flows from operating activities
Net Income
-164,574
-164,574
-94,654
-86,558
-84,038
Depreciation & amortization
2,252
2,252
2,706
3,018
3,035
Stock based compensation
10,434
10,434
11,410
10,354
10,939
Change in working capital
5,055
5,055
-5,517
-10,602
10,052
Accounts receivable
-
-
0
7
19,993
Accounts Payable
5,133
5,133
2,766
48
-1,057
Other working capital
-109,979
-109,979
-124,306
-100,785
-60,700
Other non-cash items
650
650
953
706
2,322
Net cash provided by operating activites
-109,707
-109,707
-123,065
-99,540
-57,364
Cash flows from investing activities
Investments in property, plant and equipment
-272
-272
-1,241
-1,245
-3,336
Purchases of investments
0
-50,968
0
-51,408
0
Sales/Maturities of investments
87,017
87,017
68,426
0
50,000
Net cash used for investing activites
37,337
37,337
67,185
-52,653
46,664
Cash flows from financing activities
Debt repayment
-65
-65
-291
-265
-241
Common stock issued
43,270
43,270
119,761
70,337
102,273
Common stock repurchased
0
0
-81
-
-
Other financing activites
-
-
11,438
-41
-207
Net cash used privided by (used for) financing activities
43,462
43,462
131,045
70,511
142,953
Net change in cash
-28,908
-28,908
75,165
-81,682
132,253
Cash at beginning of period
170,553
170,553
95,388
177,070
44,817
Cash at end of period
141,645
141,645
170,553
95,388
177,070
Free Cash Flow
Operating Cash Flow
-109,707
-109,707
-123,065
-99,540
-57,364
Capital Expenditure
-272
-272
-1,241
-1,245
-3,336
Free Cash Flow
-109,979
-109,979
-124,306
-100,785
-60,700